RAM IT Horny Goat Weed Dietary Supplement Recalled for Undeclared Sildenafil
Integrity Products recalls RAM IT Horny Goat Weed dietary supplement capsules nationwide because they contain undeclared sildenafil, a prescription drug not listed on the label.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: FDA Class I classification requires a minimum severity score of 4 per the regulatory rubric. The undeclared presence of a pharmaceutical drug in a dietary supplement marketed without approval constitutes a serious regulatory violation, though no illnesses or injuries have been reported.
Plain-English summary
Integrity Products is recalling RAM IT Horny Goat Weed dietary supplement capsules because they contain undeclared sildenafil. Lot HGW221116 (Batch 020123-1), expiring May 31, 2025, is affected. The recall covers approximately 2,500 boxes distributed nationwide.
Sildenafil is a prescription pharmaceutical ingredient that was not disclosed on the product label. Federal regulations require dietary supplements containing drug ingredients to have FDA approval through a New Drug Application (NDA) or Abbreviated New Drug Application (ANDA) before marketing. This product was distributed without such approval.
Consumers who have purchased this product should stop using it immediately and consult a healthcare provider if they have consumed it.
The recalled product
- Product
- RAM IT, Horny Goat Weed, dietary supplement capsules, 1000 mg, packaged in a box containing a 10-count blister card, Distributed By: Integrity Products, 1710 Fenpark Dr., Fenton, MO 63026
- Manufacturer
- Integrity Products
- Category
- Drug — Dietary Supplement
- Hazard
- undeclared-sildenafil
- unapproved-drug
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot HGW221116 (Batch 020123-1)
- Exp 5/31/2025
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereErythromycin Tablets Recalled for Impurity Above Acceptable Limits
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- ModeratePrimidone Tablets Recalled Due to API Cross-Contamination
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27